The role of blood glucose‐lowering drugs in the light of the UKPDS
- 1 September 1999
- journal article
- review article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 1 (s2) , 14-23
- https://doi.org/10.1046/j.1463-1326.1999.0010s2014.x
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Long-term effectiveness of a new α-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated Type 2 diabetes mellitusDiabetic Medicine, 1998
- Implications of blood glucose, insulin resistance and β-cell function in impaired glucose toleranceDiabetes Research and Clinical Practice, 1998
- Postprandial hyperglycaemia and α-glucosidase inhibitorsDiabetes Research and Clinical Practice, 1998
- The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complicationsDiabetic Medicine, 1998
- Oral Antidiabetic AgentsDrugs, 1998
- Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-upDiabetologia, 1996
- Long-Term Glycemic Control Relates to Mortality in Type II DiabetesDiabetes Care, 1995
- Postprandial versus Preprandial Blood Glucose Monitoring in Women with Gestational Diabetes Mellitus Requiring Insulin TherapyNew England Journal of Medicine, 1995
- Hyperglycemie and Microvascular and Macrovascular Disease in DiabetesDiabetes Care, 1995
- Stepwise and Combination Drug Therapy for the Treatment of NIDDMDiabetes Care, 1994